GREENLAND MINES LTD Cash and Cash Equivalents, Fair Value Disclosure
GREENLAND MINES LTD (GRML) had Cash and Cash Equivalents, Fair Value Disclosure of $8.88 million as of 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:CashAndCashEquivalentsFairValueDisclosure · last filed 2026-08-17
- 2026-06-30: Cash and Cash Equivalents, Fair Value Disclosure $8.88M.
- 2026-03-31: Cash and Cash Equivalents, Fair Value Disclosure $9.43M.
- 2025-12-31: Cash and Cash Equivalents, Fair Value Disclosure $7.03M.
- 2025-09-30: Cash and Cash Equivalents, Fair Value Disclosure $7.13M.
| Period end | Cash and Cash Equivalents, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $8.88M 10-Q · filed 2026-08-17 |
| 2026-03-31 | $9.43M 10-Q/A · filed 2026-08-14 |
| 2025-12-31 | $7.03M 10-Q · filed 2026-08-17 |
| 2025-09-30 | $7.13M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $8.26M 10-Q · filed 2025-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |